These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 27882085)

  • 1. Knockdown of KLK11 inhibits cell proliferation and increases oxaliplatin sensitivity in human colorectal cancer.
    Xu Z; Chi P; Pan J; Shen S; Sun Y; Wang X; Lu X
    Exp Ther Med; 2016 Nov; 12(5):2855-2860. PubMed ID: 27882085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of KLK11 reverses oxaliplatin resistance by inhibiting proliferation and activating apoptosis via suppressing the PI3K/AKT signal pathway in colorectal cancer cell.
    Zhang Y; Xu Z; Sun Y; Chi P; Lu X
    Onco Targets Ther; 2018; 11():809-821. PubMed ID: 29497313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of ADAM17 inhibits cell proliferation and increases oxaliplatin sensitivity in HCT-8 colorectal cancer through EGFR-PI3K-AKT activation.
    Zhang Q; Wang C; Han X; Yang G; Ge Z; Zhang G
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2333-2339. PubMed ID: 29964008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of YEATS4 by miR-218 sensitizes colorectal cancer cells to L-OHP-induced cell apoptosis by inhibiting cytoprotective autophagy.
    Fu Q; Cheng J; Zhang J; Zhang Y; Chen X; Xie J; Luo S
    Oncol Rep; 2016 Dec; 36(6):3682-3690. PubMed ID: 27779719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyr61 mediates oxaliplatin resistance in colorectal cancer cells by regulating Bcl-xL expression.
    Song Y; Kang Y; Lin Z; Zeng M; Shi P; Lin J; Lu P; Luo L; Cao Y; Zhu X
    J Cancer; 2021; 12(7):1952-1959. PubMed ID: 33753993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gambogic acid reverses oxaliplatin resistance in colorectal cancer by increasing intracellular platinum levels.
    Wang Q; Wei J; Wang C; Zhang T; Huang D; Wei F; He F; Cai W; Yang P; Zeng S; Li W; Cao J
    Oncol Lett; 2018 Aug; 16(2):2366-2372. PubMed ID: 30008940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal effect of ginsenoside Rh2 on oxaliplatin-resistant colon cancer cells and its mechanism.
    Ma J; Gao G; Lu H; Fang D; Li L; Wei G; Chen A; Yang Y; Zhang H; Huo J
    Exp Ther Med; 2019 Jul; 18(1):630-636. PubMed ID: 31258699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnane X receptor is associated with unfavorable survival and induces chemotherapeutic resistance by transcriptional activating multidrug resistance-related protein 3 in colorectal cancer.
    Dong Y; Wang Z; Xie GF; Li C; Zuo WW; Meng G; Xu CP; Li JJ
    Mol Cancer; 2017 Mar; 16(1):71. PubMed ID: 28356150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of GRP78 sensitizes human colorectal cancer cells to oxaliplatin by downregulation of CD24.
    Xi J; Chen Y; Huang S; Cui F; Wang X
    Oncol Lett; 2018 Jun; 15(6):9861-9867. PubMed ID: 29805687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypermethylated and downregulated MEIS2 are involved in stemness properties and oxaliplatin-based chemotherapy resistance of colorectal cancer.
    Wang X; Ghareeb WM; Zhang Y; Yu Q; Lu X; Huang Y; Huang S; Sun Y; Chi P
    J Cell Physiol; 2019 Aug; 234(10):18180-18191. PubMed ID: 30859572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KLK11 suppresses cellular proliferation via inhibition of Wnt/β-catenin signaling pathway in esophageal squamous cell carcinoma.
    He X; Meng F; Qin L; Liu Z; Zhu X; Yu Z; Zheng Y
    Am J Cancer Res; 2019; 9(10):2264-2277. PubMed ID: 31720087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dichloroacetate Overcomes Oxaliplatin Chemoresistance in Colorectal Cancer through the miR-543/PTEN/Akt/mTOR Pathway.
    Liang Y; Zhu D; Zhu L; Hou Y; Hou L; Huang X; Li L; Wang Y; Li L; Zou H; Wu T; Yao M; Wang J; Meng X
    J Cancer; 2019; 10(24):6037-6047. PubMed ID: 31762813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of Mir-135b Sensitizes Colorectal Cancer Cells to Oxaliplatin-Induced Apoptosis Through Increase of FOXO1.
    Qin Y; Li L; Wang F; Zhou X; Liu Y; Yin Y; Qi X
    Cell Physiol Biochem; 2018; 48(4):1628-1637. PubMed ID: 30071508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitrogen permease regulator-like 2 enhances sensitivity to oxaliplatin in colon cancer cells.
    Liu MN; Liu AY; Du YJ; Pei FH; Wang XH; Chen J; Liu D; Liu BR
    Mol Med Rep; 2015 Jul; 12(1):1189-96. PubMed ID: 25777765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-124 Intensified Oxaliplatin-Based Chemotherapy by Targeting CAPN2 in Colorectal Cancer.
    Xie XQ; Wang MJ; Li Y; Lei LP; Wang N; Lv ZY; Chen KL; Zhou B; Ping J; Zhou ZG; Sun XF
    Mol Ther Oncolytics; 2020 Jun; 17():320-331. PubMed ID: 32382656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioactive Peptides Sensitize Cells to Anticancer Effects of Oxaliplatin in Human Colorectal Cancer Xenografts in Nude Mice.
    Li X; Xia L; Ouyang X; Suyila Q; Su L; Su X
    Protein Pept Lett; 2019; 26(7):512-522. PubMed ID: 30950338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined chemotherapy of hydroxycampothecin with oxaliplatin as an adjuvant treatment for human colorectal cancer.
    Yao Y; Zhao H; Sun Y; Lin F; Tang L; Chen P
    Tohoku J Exp Med; 2008 Jul; 215(3):267-78. PubMed ID: 18648187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA CASC9 interacts with CPSF3 to regulate TGF-β signaling in colorectal cancer.
    Luo K; Geng J; Zhang Q; Xu Y; Zhou X; Huang Z; Shi KQ; Pan C; Wu J
    J Exp Clin Cancer Res; 2019 Jun; 38(1):249. PubMed ID: 31186036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTBP1 knockdown overcomes the resistance to vincristine and oxaliplatin in drug-resistant colon cancer cells through regulation of glycolysis.
    Cheng C; Xie Z; Li Y; Wang J; Qin C; Zhang Y
    Biomed Pharmacother; 2018 Dec; 108():194-200. PubMed ID: 30219676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEG-liposomal oxaliplatin induces apoptosis in human colorectal cancer cells via Fas/FasL and caspase-8.
    Yang C; Liu HZ; Fu ZX
    Cell Biol Int; 2012 Mar; 36(3):289-96. PubMed ID: 21888623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.